134 related articles for article (PubMed ID: 6974396)
1. [C-reactive protein: should it be determined in inflammatory rheumatic diseases?].
Schwarz HA
Schweiz Med Wochenschr; 1980 Dec; 110(51):1962-5. PubMed ID: 6974396
[TBL] [Abstract][Full Text] [Related]
2. Biological markers in inflammatory rheumatic diseases.
Hilliquin P
Cell Mol Biol (Noisy-le-grand); 1995 Dec; 41(8):993-1006. PubMed ID: 8747080
[TBL] [Abstract][Full Text] [Related]
3. [Diagnostic value of C-reactive protein in comparison with erythrocyte sedimentation as routine admission diagnostic test].
Buess T; Ludwig C
Schweiz Med Wochenschr; 1995 Jan; 125(4):120-4. PubMed ID: 7878400
[TBL] [Abstract][Full Text] [Related]
4. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers.
Keyszer G; Lambiri I; Nagel R; Keysser C; Keysser M; Gromnica-Ihle E; Franz J; Burmester GR; Jung K
J Rheumatol; 1999 Feb; 26(2):251-8. PubMed ID: 9972954
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation of the usefulness of suction drainage in the treatment of nonspecific bone infections monitored with C-reactive protein].
Milankov M; Jovanović A; Milicić A; Somer T; Vukadinović S; Savić D
Med Pregl; 1999; 52(11-12):489-94. PubMed ID: 10748773
[TBL] [Abstract][Full Text] [Related]
6. C-Reactive protein and its implications in systemic lupus erythematosus.
de Carvalho JF; Hanaoka B; Szyper-Kravitz M; Shoenfeld Y
Acta Reumatol Port; 2007; 32(4):317-22. PubMed ID: 18159197
[TBL] [Abstract][Full Text] [Related]
7. C-reactive protein in the differential diagnosis between infection and disease reactivation in SLE.
Bravo MG; Alarcon-Segovia D
J Rheumatol; 1981; 8(2):291-4. PubMed ID: 7230160
[TBL] [Abstract][Full Text] [Related]
8. Anti-lipoprotein lipase antibodies: a new player in the complex atherosclerotic process in systemic lupus erythematosus?
de Carvalho JF; Borba EF; Viana VS; Bueno C; Leon EP; Bonfá E
Arthritis Rheum; 2004 Nov; 50(11):3610-5. PubMed ID: 15529371
[TBL] [Abstract][Full Text] [Related]
9. Unresponsiveness of C-reactive protein in the non-infectious inflammation of systemic lupus erythematosus is associated with interleukin 6.
Suh CH; Chun HY; Ye YM; Park HS
Clin Immunol; 2006 Jun; 119(3):291-6. PubMed ID: 16406714
[TBL] [Abstract][Full Text] [Related]
10. Antibodies to C reactive protein.
Rosenau BJ; Schur PH
Ann Rheum Dis; 2006 May; 65(5):674-6. PubMed ID: 16176996
[TBL] [Abstract][Full Text] [Related]
11. Clinical utility of common serum rheumatologic tests.
Lane SK; Gravel JW
Am Fam Physician; 2002 Mar; 65(6):1073-80. PubMed ID: 11925083
[TBL] [Abstract][Full Text] [Related]
12. Erythrocyte sedimentation rate and C-reactive protein in the evaluation of disease activity and severity in polymyalgia rheumatica: a prospective follow-up study.
Cantini F; Salvarani C; Olivieri I; Macchioni L; Ranzi A; Niccoli L; Padula A; Boiardi L
Semin Arthritis Rheum; 2000 Aug; 30(1):17-24. PubMed ID: 10966209
[TBL] [Abstract][Full Text] [Related]
13. Pathogenic implications for autoantibodies against C-reactive protein and other acute phase proteins.
Sjöwall C; Wetterö J
Clin Chim Acta; 2007 Mar; 378(1-2):13-23. PubMed ID: 17239838
[TBL] [Abstract][Full Text] [Related]
14. Anti-telomere antibodies in systemic lupus erythematosus (SLE): a comparison with five antinuclear antibody assays in 430 patients with SLE and other rheumatic diseases.
Salonen EM; Miettinen A; Walle TK; Koskenmies S; Kere J; Julkunen H
Ann Rheum Dis; 2004 Oct; 63(10):1250-4. PubMed ID: 15361381
[TBL] [Abstract][Full Text] [Related]
15. Serum thrombomodulin in systemic lupus erythematosus and juvenile idiopathic arthritis.
el-Gamal YM; Heshmat NM; el-Kerdany TH; Fawzy AF
Pediatr Allergy Immunol; 2004 Jun; 15(3):270-7. PubMed ID: 15209962
[TBL] [Abstract][Full Text] [Related]
16. CRP and the disposal of dying cells: consequences for systemic lupus erythematosus and rheumatoid arthritis.
Vogt B; Führnrohr B; Müller R; Sheriff A
Autoimmunity; 2007 Jun; 40(4):295-8. PubMed ID: 17516213
[TBL] [Abstract][Full Text] [Related]
17. Use of C-reactive protein after spinal surgery: comparison with erythrocyte sedimentation rate as predictor of early postoperative infectious complications.
Mok JM; Pekmezci M; Piper SL; Boyd E; Berven SH; Burch S; Deviren V; Tay B; Hu SS
Spine (Phila Pa 1976); 2008 Feb; 33(4):415-21. PubMed ID: 18277874
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory mechanisms affecting the lipid profile in patients with systemic lupus erythematosus.
Chung CP; Oeser A; Solus J; Avalos I; Gebretsadik T; Shintani A; Linton MF; Fazio S; Stein CM
J Rheumatol; 2007 Sep; 34(9):1849-54. PubMed ID: 17659756
[TBL] [Abstract][Full Text] [Related]
19. C-reactive protein: a sensitive marker in the management of treatment response in parapneumonic empyema of children.
Dilber E; Cakir M; Kalyoncu M; Okten A
Turk J Pediatr; 2003; 45(4):311-4. PubMed ID: 14768795
[TBL] [Abstract][Full Text] [Related]
20. Autoantibodies against C-reactive protein: clinical associations in systemic lupus erythematosus and primary antiphospholipid syndrome.
Figueredo MA; Rodriguez A; Ruiz-Yagüe M; Romero M; Fernandez-Cruz A; Gomez-de la Concha E; Patiño R
J Rheumatol; 2006 Oct; 33(10):1980-6. PubMed ID: 17014014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
